Vacinar ou arriscar? A mensagem da Organização Mundial de Saúde para promover a vacinação contra a covid-19 / Vaccinate or taking chances? The World Health Organization's message to promote vaccination against COVID-19

Resumo Centrando-se no impacto que a comunicação de risco emitida pelas organizações de saúde pública tem na mudança dos comportamentos da sociedade, esta investigação pretende analisar as mensagens-chave que a Organização Mundial de Saúde (OMS) definiu para promover o programa de vacinação contra a covid-19. Para cumprir este objetivo, enveredou-se por uma metodologia de estudo qualitativa, que privilegiou o uso da análise do conteúdo publicado nas páginas de Facebook e de Instagram da OMS, no período de 1 de abril a 31 de agosto de 2021. No total, foram analisadas 62 publicações. Os resultados mostraram que a OMS utilizou quatro eixo de comunicação para promover a importância da vacinação na sociedade: garantir a credibilidade e a transparência da informação transmitida; certificar a segurança e a eficácia da vacina; apelar ao sentido de responsabilidade coletiva; e associar a vacina à solução para pôr fim à pandemia. As conclusões do estudo mostram que, embora a equidade no acesso à vacina ainda seja uma realidade em construção, os quase 70% da população mundial vacinada sugerem que as mensagens enviadas pela OMS no contexto de comunicação de risco podem ter contribuído para a construção de uma imagem positiva do programa de vacinação.

Abstract Focusing on the impact that risk communication issued by public health organizations brings to changing societal behaviors, this research aimed to analyze the key messages that the World Health Organization (WHO) has defined to promote the COVID-19 vaccination program. In order to achieve this goal, a qualitative study methodology was used to analyze the content published on the WHO's Facebook and Instagram pages from April 1 to August 31, 2021. In total, 62 publications were analyzed. The results showed that the WHO used four key communication messages to promote the importance of vaccination in society: ensuring the credibility and transparency of the information transmitted; certifying the safety and efficacy of the vaccine; appealing to a sense of collective responsibility; and associating the vaccine with the solution to end the pandemic were the chosen communication axes. The conclusions of this study show that, although fair access to the vaccine is still a reality in the making, the fact that almost 70% of the world's population has been vaccinated suggests that the messages sent by the WHO in the context of risk communication may have contributed to building a positive image of the vaccination program.

Bellini duct carcinoma

The modern era has brought an appreciation that renal cell carcinoma (RCC) includes diverse subtypes derived from the various parts of the nephron, each with its distinctive genetic basis and tumor biology. Carcinoma of the collecting ducts of Bellini (CDC) is a rare subtype of RCC, with a predictably poor prognosis. This rare subtype represents less than 1% of all kidney carcinomas. It derives from presumably numerous chromosomal losses. It is of chief importance to differentiate CDC from other types of renal cell cancer. Typically, it is characterized by a firm, centrally located tumor with infiltrative borders. Regarding the histopathologic characteristics, we can find complex, highly infiltrative cords with inflamed (desmoplastic) stroma, with high-grade nuclei and mitoses. Most reported cases of CDC had been high grade, advanced stage, and unresponsive to conventional therapies. This rare form of disease highlights the importance of multidisciplinary teams in the management of cancer patients.

Late-onset of eruptive syringomas: a diagnostic challenge

Syringoma is a benign, adnexal tumor of the eccrine sweat gland ducts. Eruptive syringomas are a rare variant, occurring before or during puberty in most cases. A 57-year-old man was observed in our department, with a 10-year history of multiple brownish papules (1-4mm in diameter), localized on the neck, shoulders, trunk and axillae. The clinical diagnosis was cutaneous mastocytosis. Histopathological examination from a papule in the trunk was compatible with the diagnosis of syringoma. The patient was treated with isotretinoin, without any improvement. The clinical diagnosis of eruptive syringoma is diffi cult and histological examination is crucial for its diagnosis. Long-term morbidity is not associated with syringomas; they are treated for cosmetic reasons with unsatisfactory results.

Kikuchi´s disease of the xanthomathous type with cutaneous manifestations

Kikuchi's disease is a benign, self-limiting disease, whose pathogenesis remains unknown. Patients most often present with cervical lymphadenopathy, sometimes associated with fever and leukopenia. It has been reported that up to 40% of patients with Kikuchi's disease have also cutaneous eruptions, but no specific skin changes have been described. Kikuchi's disease can be subclassified into three histologic subtypes: a proliferative type, a necrotizing type and a xantomathous type. Most patients with Kikuchi's disease require no specific treatment, because the disease regresses spontaneously, within a few weeks to months. We report a case of a 31-year-old woman with xanthomatous type of Kikuchi's disease, whose first manifestation was the onset of erythematous papules with central suppuration on her face and on her left hand.

Variáveis relacionadas ao Trypanosoma Cruzi (Chagas, 1909) ao vetor Triatoma Brasiliensis (NEIVA, 1911) que interferem na interação parasita-hospedeiro / Variable related to the Trypanosoma Cruzi (Chagas, 1909) to the vector Triatoma Brasiliensis (NEIVA, 1911) intervene with the interaction parasite-host

Devido a estrutura multiclonal do Trypanosoma cruzi (Chagas, 1909),e sua extrema variabilidade genética, diversos estudos de caracterização enzimática (zimodemas) e molecular de diferentes subpopulações deste parasita foram realizados, definindo-se então duas principais linhagens distintas e distantes filogenéticamente: T. cruzi (TcI e TcII). O primeiro aspecto abordado neste trabalho, tratou-se de diferenciar as principais subpopulações do T. cruzi in vitro, utilizando lectinas como marcadores bioquímicos. Posteriormente, para compreendermos o comportamento entre as duas linhagens de T. cruzi, foram avaliadas a cinética de co-cultivo envolvendo TcI e TcII em meio axênico e no trato digestivo de Triatoma brasiliensis (Neiva, 1911). A segunda parte do presente trabalho está relacionada ao estudo dos mecanismos de defesa deste vetor, uma vez que os insetos sintetizam inúmeros peptídeos antimicrobianos em resposta a uma infecção por bactérias ou por qualquer outro agente patógeno. Sabe-se que estes peptídeos fazem parte da immunidade inata dos insetos e possuem propriedades de lisar bactérias Gram-positivas e Gram-negativas.Para isso, genes que codificam lisozimas e defensinas do trato digestivo de T. brasiliensis, foram isolados, caracterizados e sequenciados. As defensinas são encontradas em diversas espécies de insetos, mamíferos e plantas, e pertencem ao grupo de peptídeos ricos em cisteínas, sendo extremamente ativas contra bactérias Gram-positiva. As lisozimas também são encontradas em insetos de diferentes ordens e em alguns gêneros como Drosophila e Musca, podem atuar como enzimas digestivas. Além do isolamento e caracterização destes peptídeos, também avaliamos os padrões de expressão dos mesmos, em diferentes segmentos do trato digestivo do inseto vetor, através das técnicas de hibridização in situ e PCR tempo-real.

Studies on the effectiveness of diarylheptanoids derivatives against Leishmania amazonensis

In a previous work we demonstrated that diarylheptanoids extracted from Centrolobium sclerophyllum are very active against Leishmania amazonensis promastigotes. In order to continue our studies with these class of compounds, we decided to evaluate the activity of several diarylheptanoids derived from curcumin (diferuloyl methane) against the extracellular form (promastigotes) of L. amazonensis. Furthermore, an experiment against the intracellular form of the parasite (amastigotes) was carried out, comparing the most active compound among the curcumin derivatives (the methylcurcumin) with des-O-methylcentrolobine, the most active diarylheptanoid derived from C. sclerophyllum